openPR Logo
Press release

Cancer Biological Therapy Market Astonishing Growth | ELI Lilly,F. Hoffmann-La Roche, GlaxoSmithKline, Incyte, Merck, Novartis,AbbVie, Amgen, Astellas, AstraZeneca, Bayer

04-01-2019 07:43 PM CET | Business, Economy, Finances, Banking & Insurance

Press release from: MarketStudyReport

Cancer Biological Therapy Market Astonishing Growth | ELI

MarketStudyReport.com Adds New Cancer Biological Therapy Market 2018 – 2024 research report providing information and data By Product, Industry Analysis, Regional Outlook (North America, Europe, Asia Pacific, MEA), Application Potential, Competitive Market Share & Forecast spreading across 200 Pages with table and figures in it.

Germany cancer biological therapy market was valued at USD 4.0 billion in 2017. Increasing prevalence of cancer in Germany will surge demand for cancer biologics therapy. High prevalence of cancer will propel demand for cancer biologics thereby, enhancing Germany cancer biologics industry growth.

Request a sample of this premium report at: www.marketstudyreport.com/request-a-sample/467761/?utm_source=openpr.com&utm_medium=dc

Cancer Biological Therapy Market will exceed USD 108 billion by 2024; as per a new research report. Growing geriatric population will drive cancer biological therapy industry growth during forecast timeframe. Elderly population in the age group of 50 years and above is more susceptible to cancer that escalates demand for cancer biologic therapies. Cancer biological therapy is utilized to boost immune system and has commendable specificity that helps in faster recovery. High preference for cancer biological therapy for treating geriatric population suffering from cancer will positively influence industry growth over forthcoming years.

Vaccines segment was valued at USD 2.0 billion in 2017 and is expected to have considerable revenue size over forthcoming years. Vaccines utilized in cancer treatment possess high efficiency and have ability to increase immunity by recognizing and destroying specific antigens. Moreover, vaccines also create immunogenic response that reduces risk of acquiring cancer again in future and are most effective in treatment of bladder, breast and cervical cancer. Aforementioned factors coupled with growing incidences of breast cancer in developing economies such as India will stimulate segmental growth.

Increasing R&D funding by government in various pharmaceutical, biopharmaceutical companies as well as research institutes involved in developing cancer drugs will foster cancer biologics market growth. Funds raised by governments in developed countries such as UK have facilitated cancer drug discovery process and has also enhanced operational capabilities of the companies and research centers involved in developing cancer biological therapy drugs and vaccines. Moreover, favorable government policies and regulatory framework facilitating drug discovery process will substantially augment cancer biologics industry growth. However, adverse effects of anti-cancer drug therapy may lower its preference and hamper business growth up to some extent.

Request a discount on standard prices of this premium report at: www.marketstudyreport.com/check-for-discount/467761/?utm_source=openpr.com&utm_medium=dc

Some of the eminent industry players operating in cancer biological therapy industry includes AbbVie, Amgen, Astellas, AstraZeneca, Bayer, Celgene Corporation, Eisai, ELI Lilly and Company, F. Hoffmann-La Roche, GlaxoSmithKline, Incyte, Merck, Novartis, Otsuka, Pfizer, Sanofi, Seattle Genetics, Spectrum Pharmaceuticals and Takeda Pharmaceuticals. Key industry players implement several strategies such as mergers, acquisition, geographic expansions and new product launch that enables them to achieve sustainable profits. Receiving FDA approvals for newly developed drugs will also foster company?s revenue generation. For instance, in November 2018, Roche and Abbvie received FDA approval for Venclexta, a BCL-2 inhibitor effective in the treatment of leukemia. Venclexta is jointly commercialized by Abbvie and Genetech, a part of Roche Group in the U.S. and is sold solely by Abbvie outside of the U.S. Receiving approvals for new drugs will boost Abbvie?s as well as Roche?s profits.

Table of Content:

Chapter 1. Methodology

1.1. Methodology

1.2. Market definitions

1.3. Forecast parameters

1.4. Data sources

1.4.1. Secondary

1.4.1.1. Paid sources

1.4.1.2. Unpaid sources

1.4.2. Primary

Chapter 2. Executive Summary

2.1. Cancer biological therapy industry 360 degree synopsis, 2013 - 2024

2.1.1. Business trends

2.1.2. Product trends

2.1.3. Regional trends

Chapter 3. Cancer Biological Therapy Industry Insights

3.1. Industry segmentation

3.2. Industry landscape, 2013 - 2024

3.3. Industry impact forces

3.3.1. Growth drivers

3.3.1.1. Increasing incidence of cancer worldwide

3.3.1.2. Growing geriatric population

3.3.1.3. Technological advancement in cancer biologics in developed countries

3.3.1.4. Increasing R&D funding coupled with favorable government policies

3.3.2. Industry pitfalls and challenges

3.3.2.1. High cost of treatment

3.3.2.2. Adverse effects of anti-cancer drug therapy

3.4. Growth potential analysis

3.4.1. By product

3.5. Porter's analysis

3.6. Competitive landscape, 2017

3.6.1. Strategy dashboard

3.7. PESTEL analysis

Chapter 4. Cancer Biological Therapy Market, By Product

4.1. Key segment trends

4.2. Monoclonal antibodies (MAB)

4.2.1. Market size, by region, 2013 - 2024

4.2.2. Naked MAB

4.2.2.1. Market size, by region, 2013 - 2024

4.2.3. Conjugated MAB

4.2.3.1. Market size, by region, 2013 - 2024

4.2.4. Bispecific MAB

4.2.4.1. Market size, by region, 2013 - 2024

4.3. Vaccines

4.3.1. Market size, by region, 2013 - 2024

4.3.2. Preventive vaccines

4.3.2.1. Market size, by region, 2013 - 2024

4.3.3. Therapeutic vaccines

4.3.3.1. Market size, by region, 2013 - 2024

4.4. Cancer growth blockers

4.4.1. Market size, by region, 2013 - 2024

4.4.2. Tyrosine kinase Inhibitors (TKI)

4.4.2.1. Market size, by region, 2013 - 2024

4.4.3. Proteasome Inhibitors (PI)

4.4.3.1. Market size, by region, 2013 - 2024

4.4.4. mTOR Inhibitors

4.4.4.1. Market size, by region, 2013 - 2024

4.5. Blood cell growth factors (BCGF)

4.5.1. Market size, by region, 2013 - 2024

4.5.2. Lenograstim

4.5.2.1. Market size, by region, 2013 - 2024

4.5.3. Filgrastim

4.5.3.1. Market size, by region, 2013 - 2024

4.6. Cytokines

4.6.1. Market size, by region, 2013 - 2024

4.6.2. Interferons

4.6.2.1. Market size, by region, 2013 - 2024

4.6.3. Interleukins

4.6.3.1. Market size, by region, 2013 - 2024

Chapter 5. Cancer Biological Therapy Market, By Region

Chapter 6. Company Profiles

For More Details On this Report: https://www.marketstudyreport.com/reports/cancer-biological-therapy-market/?utm_source=openpr.com&utm_medium=dc

About Us:

Marketstudyreport.com allows you to manage and control all corporate research purchases to consolidate billing and vendor management. You can eliminate duplicate purchases and customize your content and license management.

Contact Us:
Market Study Report LLC.
4 North Main Street,
Selbyville, Delaware 19975
USA
Phone: 1-302-273-0910
US Toll Free: 1-866-764-2150
Email: sales@marketstudyreport.com
Website: www.marketstudyreport.com
Blog: www.marketstudyreport.com/blog

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Cancer Biological Therapy Market Astonishing Growth | ELI Lilly,F. Hoffmann-La Roche, GlaxoSmithKline, Incyte, Merck, Novartis,AbbVie, Amgen, Astellas, AstraZeneca, Bayer here

News-ID: 1682013 • Views: 437

More Releases from MarketStudyReport

Medical Automation Technologies Market Analysis by Top Manufacturers, Shares, Gr …
Market Study Report, LLC's latest research report on Medical Automation Technologies Market, delivers a comprehensive study on current market trends. The outcome also includes revenue forecasts, statistics, Medical Automation Technologies market valuations which illustrates its growth trends and competitive landscape as well as the key players in the business. Request a sample Report of Medical Automation Technologies Market at: https://www.marketstudyreport.com/request-a-sample/1524757?utm_source=openpr.com&utm_medium=PC Medical automation technologies is an independent of efficient, effective and equitable
What's driving the Automotive Diagnostic Scan Tools Market trends? Key Players a …
MarketStudyReport.com Adds New Report Automotive Diagnostic Scan Tools Market 2019 - 2025 research report providing information and data By Offering, Diagnostic Software, Diagnostic Services, By Application, By Tool Type, Industry Analysis, Regional Outlook, Growth Potential, Competitive Market Share & Forecast spreading across 320 Pages with table and figures in it. Europe is anticipated to be the prominent region in the automotive diagnostic scan tools market with the market share of over
Comprehensive analysis on Endpoint Security Market| Key Players are F-Secure, We …
MarketStudyReport.com Adds New Endpoint Security Market 2017 - 2024 research report providing information and data By Component, By Service, By Application, Industry Analysis, Regional Outlook, Growth Potential, Trends, By Deployment Model, Competitive Market Share & Forecast spreading across 380 Pages with table and figures in it. North America dominated the endpoint protection market in 2016 and is projected to maintain the dominance throughout the forecast period, primarily due to large-scale deployment
Veterinary Vaccines Market is Booming 2019 | By Players include Zoetis Inc. Merc …
Vaccines play a crucial role in protecting animals from a large spectrum of diseases caused due to virus, bacteria, protozoa, and other multicellular pathogens. Request a sample of this premium report at: https://www.marketstudyreport.com/request-a-sample/1513665/?utm_source=Openpr&utm_medium=RV The global veterinary vaccines market is expected to benefit from the growing concern over food safety. The dependency on livestock products

All 5 Releases


More Releases for Cancer

Cancer Therapeutics Market New Business Opportunities to Hit $180.19 billion by …
Surge in geriatric population and rise in the number of collaborations & partnerships to facilitate drug development are the key drivers of the global cancer therapeutics market. In addition, heavy inflow of investment in R&D activities has enhanced the development of cancer therapeutics. Furthermore, favorable government regulations for cancer therapeutics and surge in cancer prevalence boost the market. The high demand for personalized medicine along with high potential of emerging
Primary Prevention of Cancer
Primary prevention of cancer aims to prevent the disease before it ever occurs. More than 4 in 10 cancers as well as cancer deaths are linked to modifiable risk factors that can be altered as part of primary cancer prevention. The modifiable risk factors for primary prevention include: 1. Cigarette smoking: Smoking causes almost all cases of lung cancer and accounts for 30% of all cancer deaths. Prevention strategy for this risk
Cancer Vaccines Market
Manufacturers in the cancer vaccines market are focusing on developing new vaccines in order to treat various cancers. Through this, they are expected to gain a competitive edge in the market and increase their market share. For instance, Gilead Science Inc., in 2017, acquired Kite Pharma Inc., which is involved in development of different type of immunotherapy and vaccines. Also, Treos Bio, in 2017, collaborated with Pharmaceutical Product Development, LLC
Cancer Diagnostics Global Market: By Application - Breast Cancer, Lung Cancer, C …
Researchmoz added Most up-to-date research on "Cancer Diagnostics Global Market: By Application - Breast Cancer, Lung Cancer, Colorectal Cancer, Melanoma & Other Cancers" to its huge collection of research reports. This report studies Cancer Diagnostics in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022. This report focuses on top
Global Cancer Vaccines Market 2016: Liver cancer, Cervical cancer, Stomach cance …
Latest industry research report on Cancer vaccines are the type of immunotherapy (also named as biologic therapy), designed to boost body's natural defense against cancer. The body's natural immune system recognizes vaccine proteins as the foreign particles and sets up an immunity against them. According to World Health Organization (WHO), cancer is a leading cause of worldwide mortality registering ~14 million new cases and ~8.2 million cancer-related diseases in 2012. Personalized
Taking thyroid cancer seriously
With the increasing incidence rate of thyroid cancer in Metro Cebu, the Eduardo J. Aboitiz Cancer Center (EJACC) of the Ramon Aboitiz Foundation Inc. (RAFI) urged the public to undergo early screening and prevention measures to fight the disease. “Thyroid cancer is high on prognosis. It is preventable through various screening methods, such as physical examination and ultrasound of the neck, as well as some prevention measures, including regular exercise and